|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| License | |||||
| Collaboration | |||||
| Total revenues | |||||
| Operating expenses: | |||||
| Research and development | |||||
| Selling, general and administrative | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other income (expense), net: | |||||
| Interest and other income | |||||
| Interest and other expense | |||||
| Interest income | |||||
| Interest expense | |||||
| Other expense, net | |||||
| Total other income, net | |||||
| Net loss | |||||
| Other comprehensive income (loss): | |||||
| Unrealized gain (loss) on available-for-sale securities | |||||
| Total other comprehensive income (loss) | |||||
| Comprehensive loss | |||||
| Net loss per share, basic (in dollars per share) | |||||
| Common Stock | |||||
| Total net loss per share, basic (in dollars per share) | |||||
| Net loss per share, diluted (in dollars per share) | |||||
| Common Stock | |||||
| Total net loss per share, diluted (in dollars per share) | |||||
| Weighted-average shares outstanding, basic (in shares) | |||||
| Common Stock | |||||
| Total weighted-average shares outstanding, basic (in shares) | |||||
| Weighted-average shares outstanding, diluted (in shares) | |||||
| Common Stock | |||||
| Total weighted-average shares outstanding, diluted (in shares) | |||||
Loading...